Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Julià Blanco and Bonaventura Clotet.
Connection Strength

2.558
  1. Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals. Viruses. 2021 06 12; 13(6).
    View in: PubMed
    Score: 0.238
  2. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med (N Y). 2021 Mar 12; 2(3):313-320.e4.
    View in: PubMed
    Score: 0.232
  3. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021 01 28; 11(1):2608.
    View in: PubMed
    Score: 0.232
  4. Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity. Biochem Biophys Res Commun. 2021 01 29; 538:187-191.
    View in: PubMed
    Score: 0.228
  5. Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Front Immunol. 2018; 9:2429.
    View in: PubMed
    Score: 0.198
  6. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan 14; 32(2):149-160.
    View in: PubMed
    Score: 0.188
  7. Aging in HIV-Infected Subjects: A New Scenario and a New View. Biomed Res Int. 2017; 2017:5897298.
    View in: PubMed
    Score: 0.187
  8. Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif. Sci Rep. 2017 01 13; 7:40800.
    View in: PubMed
    Score: 0.175
  9. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment. Antivir Ther. 2010; 15(3):333-42.
    View in: PubMed
    Score: 0.107
  10. On the steps of cell-to-cell HIV transmission between CD4 T cells. Retrovirology. 2009 Oct 13; 6:89.
    View in: PubMed
    Score: 0.106
  11. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021 Dec; 10(1):797-809.
    View in: PubMed
    Score: 0.061
  12. Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report. Open Forum Infect Dis. 2021 Jul; 8(7):ofab329.
    View in: PubMed
    Score: 0.060
  13. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen. Front Pharmacol. 2021; 12:646676.
    View in: PubMed
    Score: 0.059
  14. SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus. Membranes (Basel). 2021 Jan 18; 11(1).
    View in: PubMed
    Score: 0.058
  15. Pigs are not susceptible to SARS-CoV-2 infection but are a model for viral immunogenicity studies. Transbound Emerg Dis. 2021 Jul; 68(4):1721-1725.
    View in: PubMed
    Score: 0.057
  16. Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain. Proc Natl Acad Sci U S A. 2020 10 06; 117(40):24790-24793.
    View in: PubMed
    Score: 0.056
  17. Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC. Oncoimmunology. 2019; 8(8):1602460.
    View in: PubMed
    Score: 0.051
  18. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
    View in: PubMed
    Score: 0.049
  19. Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. J Antimicrob Chemother. 2018 07 01; 73(7):1940-1948.
    View in: PubMed
    Score: 0.048
  20. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery. PLoS One. 2017; 12(9):e0184433.
    View in: PubMed
    Score: 0.046
  21. Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. Front Immunol. 2017; 8:1154.
    View in: PubMed
    Score: 0.046
  22. Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery. Sci Rep. 2017 09 15; 7(1):11711.
    View in: PubMed
    Score: 0.046
  23. Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines. J Biomol Screen. 2012 Jul; 17(6):727-37.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.